COMPANY:

Lumea

"Lumea Inc...announce its strategic partnership with AiraMatrix Private Limited...This collaboration marks a significant advancement in the field, as it enables pathologists on Lumea’s diagnostic platform to use AIRA Matrix’s cutting-edge diagnostic solutions for decision support in Gleason grading prostate cancer specimens. Pathologists can utilize these diagnostic aids to improve tumor grading and enhance risk stratification."

"Lumea Inc...announce our partnership with Invitae Corporation (Invitae). This partnership will give Lumea diagnostic platform users access to easy one-click conditional ordering of Invitae tests."

"Lumea...is pleased to announce that Acupath is partnering with Lumea to adopt the Lumea+ Viewer, leveraging its modular capability, well-rounded solutions, and flexibility...Lumea+ integrates Lumea’s leading-edge technology and proprietary consumables with any existing LIS. This upgraded system provides a seamless and easy transition from traditional to digital pathology."

"Lumea...and OptraSCAN...announced a strategic commercial collaboration agreement. This agreement brings together Lumea’s comprehensive digital pathology platform with a wide range of digital scanning solutions to enable providers to adopt digital pathology efficiently and cost-effectively."